Genomic Stability and RecQ DNA Helicases in Yeast
酵母中的基因组稳定性和 RecQ DNA 解旋酶
基本信息
- 批准号:7218002
- 负责人:
- 金额:$ 28.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:Biochemical GeneticsBiological AssayBloom SyndromeCell Cycle CheckpointCellsComplexDefectFailureFamilyFlap EndonucleasesFrequenciesGene RearrangementGenesGeneticGenetic RecombinationGenome StabilityHereditary DiseaseHomologous GeneHumanLigandsMalignant NeoplasmsMeasuresModelingModificationMutationNuclear ProteinNuclear ProteinsNumbersPathway interactionsPatientsPost-Translational Protein ProcessingProteinsRecombinant DNARecombinant ProteinsRibosomal DNARoleRothmund-Thomson syndromeSaccharomycetalesStructureSystemTestingTopoisomeraseTopoisomerase IIIUbiquitinWerner SyndromeYeast Protein ComplexYeastsgenetic analysishelicasehuman RBX1 proteinhuman diseasemutantubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Loss of genome stability is associated with a number of human diseases that predispose patients to cancer. In particular, mutations in the genes encoding the RecQ family of DNA helicases have been shown to cause three distinct genetic diseases [Bloom syndrome (BLM), Werner syndrome (WRN), and a subset of Rothmund-Thomson syndrome (RTS)]. Cells from these patients display excessive DNA rearrangements suggesting that their primary defect is the failure to maintain genome stability. The only RecQ homolog in budding yeast, Sgs1, exists in a complex with DNA topoisomerase III (Top3) and serves as a model for human BLM which also bindsTop3. We have exploited the yeast system to identify genetic pathways that are functionally redundant with the RecQ-Top3 complex. Two of these pathways are defined by the Slx1-Slx4 and SIx5-SIx8 protein complexes. We have shown that Slx1-SIx4 is a 5'-flap endonuclease while SIx5-Slx8 has no known activity. Here we propose to explore the mechanism by which the RecQ-Top3 complex controls genome stability using biochemical and genetic analysis of these three complexes: Slxl-4, Slx5-8, and Sgsl-Top3. In Aim1 we will purify and characterize the Slx1-SIx4 protein complex from yeast. New subunits will be identified and tested for their effect on 5'-flap endonuclease activity. A structure-function analysis of both subunits will be conducted and the role of these proteins in cell-cycle checkpoint control will be tested. Genome stability will be assayed in mutant cells by measuring recombination frequencies and by investigating the role of the Slx1-4 complex in controlling rDNA repeat structure. The proteins' nuclear localization will also be determined. In Aim 2 we will similarly purify and characterize the Slx5-SIx8 complex. The Slx5 and Slx8 subunits are RING-finger proteins suggesting that the Slx5-8 complex may be involved in protein modification. Using purified recombinant protein we will test Slx5-8 for E3 ligase activity using Smt3 or ubiquitin as ligand. A positive result will be extended by searching for specific substrates of the modification. In Aim 3 Sgsl-Top3 will be purified and tested for DNA helicase and topoisomerase activity using substrates that have been suggested by our genetic analysis.
描述(由申请人提供):基因组稳定性的丧失与许多人类疾病有关,这些疾病使患者容易患上癌症。特别是,编码DNA解旋酶RecQ家族的基因突变已被证明导致三种不同的遗传病[Bloom综合征(BLM)、Werner综合征(WRN)和Rothmund-Thomson综合征(RTS)的子集]。这些患者的细胞表现出过度的DNA重排,这表明他们的主要缺陷是未能维持基因组的稳定。萌芽酵母中唯一的RecQ同源物SGS1存在于DNA拓扑异构酶III(Top3)的复合体中,并作为人类BLM的模型,该模型也与Top3结合。我们已经利用酵母系统来识别与RecQ-top3复合体在功能上多余的遗传途径。其中两条通路由SLX1-SLX4和SIx5-SIx8蛋白复合体定义。我们发现SIx1-SIx4是一种5‘-翻盖核酸内切酶,而SIx5-SIx8没有已知的活性。在这里,我们建议通过对三个复合体:slx1-4、slx5-8和sgsl-top3的生化和遗传分析来探索RecQ-top3复合体控制基因组稳定性的机制。在Aim1中,我们将从酵母中纯化并鉴定SLX1-SIx4蛋白复合体。新的亚基将被识别并测试它们对5‘-Flat核酸内切酶活性的影响。将对这两个亚基进行结构-功能分析,并测试这些蛋白质在细胞周期检查点控制中的作用。通过测量重组频率和研究SLX1-4复合体在控制rDNA重复结构中的作用,将在突变细胞中测试基因组的稳定性。蛋白质的核定位也将得到确定。在目标2中,我们将类似地纯化和表征SLX5-SIx8复合体。SLX5和SLX8亚基是环指蛋白,提示SLX5-8复合体可能参与蛋白质修饰。使用纯化的重组蛋白,我们将以Smt3或泛素为配基,检测SLX5-8的E3连接酶活性。通过寻找修饰的特定底物,阳性结果将得到扩展。在AIM中,3SGSL-top3将被提纯,并使用我们的遗传分析所建议的底物来测试DNA解旋酶和拓扑异构酶的活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN J. BRILL其他文献
STEVEN J. BRILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN J. BRILL', 18)}}的其他基金
Mechanism of the BLM/Sgs1 Helicase Complex
BLM/Sgs1 解旋酶复合物的机制
- 批准号:
8292698 - 财政年份:2012
- 资助金额:
$ 28.75万 - 项目类别:
Mechanism of the BLM/Sgs1 Helicase Complex
BLM/Sgs1 解旋酶复合物的机制
- 批准号:
8623139 - 财政年份:2012
- 资助金额:
$ 28.75万 - 项目类别:
Mechanism of the BLM/Sgs1 Helicase Complex
BLM/Sgs1 解旋酶复合物的机制
- 批准号:
8602662 - 财政年份:2012
- 资助金额:
$ 28.75万 - 项目类别:
Mechanism of the BLM/Sgs1 Helicase Complex
BLM/Sgs1 解旋酶复合物的机制
- 批准号:
8464168 - 财政年份:2012
- 资助金额:
$ 28.75万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 28.75万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 28.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 28.75万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 28.75万 - 项目类别:
Postdoctoral Fellowships